陳 彥舟

Medicine & Life Sciences

1. Coronary Angiography 100%
2. Type 2 Diabetes Mellitus 91%
3. Coronavirus Infections 87%
4. Ehlers-Danlos Syndrome 85%
5. Liraglutide 85%
6. Severe Acute Respiratory Syndrome 78%
7. Raynaud Disease 77%
8. Coronavirus 76%
9. Metformin 65%
10. Sodium-Glucose Transport Proteins 61%
11. Autoimmunity 59%
12. Upper Extremity 55%
13. Health Care Costs 54%
14. Cost-Benefit Analysis 52%
15. Vascular Endothelial Growth Factor A 52%
16. Coronary Vessels 49%
17. Insulin 47%
18. Thrombosis 47%
19. Costs and Cost Analysis 46%
20. Ischemia 45%
21. Quality-Adjusted Life Years 38%
22. Dipeptidyl-Peptidase IV Inhibitors 34%
23. Hospital Emergency Service 32%
24. Arteries 30%
25. Cardiovascular Diseases 29%
26. Tomography 27%
27. Fasciotomy 27%
28. Compartment Syndromes 26%
29. Coronary Circulation 26%
30. Collateral Circulation 25%
31. Elderly 24%
32. Radial Artery 24%
33. Endovascular Procedures 24%
34. Surgical Wound 24%
35. Troponin I 24%
36. Platelet Aggregation Inhibitors 23%
37. Subarachnoid Hemorrhage 21%
38. Coma 21%
39. Pharmacy 20%
40. Acute Coronary Syndrome 20%
41. Hemostasis 20%
42. Hematoma 19%
43. General Anesthesia 18%
44. National Health Programs 18%
45. Confidence Intervals 18%
46. Arm 17%
47. Taiwan 17%
48. Thromboembolism 17%
49. Inpatients 16%
50. Genetic Polymorphisms 16%